← FDA DRUG APPROVALS

FDA ANDA · ANDA200174

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

calcipotriene, betamethasone dipropionate

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA200174
TYPE
ANDA
ORIGINAL APPROVAL
2014-12-12
LATEST ACTION
2014-12-12
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEPrescription
BETAMETHASONE DIPROPIONATE 0.064%, CALCIPOTRIENE 0.005% · OINTMENT · TOPICAL

Approval history

2014-12-12Not Applicable · Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →